(Last updated by Stephan Mielke on 10/5/2008 at 11:43 AM.)
(Please use Microsoft Internet Explorer version 6.0 or higher to run this application)
Preferred Method of Contact and Additional Contact Information
Email
Education, Affiliations, and Memberships
Dr. Mielke graduated (MD) in 1999 from Georg-August University Medical School in Goettingen, Germany. After completion of his scientific thesis at the Department of Obstetrics and Gynecology he received his doctoral degree (Dr. med.) from Georg-August University. He started his residency and fellowship program at the Albert-Ludwig University of Freiburg in Germany, Department of Internal Medicine, Division of Hematology and Oncology. He was awarded a postdoctoral grant from the Dr.-Mildred-Scheel-Stiftung in Germany to carry out translational research on allogeneic stem cell transplantation at the National Institutes of Health, Bethesda, Maryland, USA. From May 2004 to August 2007 Dr. Mielke worked in the Allotransplantation Section of the Hematology Branch at the National Institutes of Health where he initiated two clinical trials on allotransplantation as the Principal Investigator. Afterwards he returned to Germany and joined the Department of Internal Medicine II at the Julius-Maximilian University of Wuerzburg where he meanwhile carries responsibilities as an attending physician at the Division of Hematology and Oncology. Clinically he focuses on matched and mismatched (haploidentical) allogeneic stem cell transplantation and optimized solid tumor therapy. His research focuses on individualized cellular, molecular and pharmacological approaches in cancer therapy.
Dr. Mielke is member of the American Society of Hematology (ASH), the European Group for Blood and Marrow Transplantation (EBMT) and the German Society of Hematology and Oncology (DGHO) and joined the Immunobiology working party of EBMT in 2008.